Cargando…

283 Gait: a biomarker for pain and function in chronic low back pain

OBJECTIVES/GOALS: Chronic low back pain (cLBP) is associated with gait impairments. Gait may serve as an important biomarker for improvement following therapy interventions; however, gait has not been sufficiently studied in relationship to pain and function in cLBP. METHODS/STUDY POPULATION: Adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailes, Anna H, Johnson, Marit E., Redfern, Mark, Perera, Subashan, Greco, Carol, Sowa, Gwendolyn, Cham, Rakie, Bell, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129838/
http://dx.doi.org/10.1017/cts.2023.339
_version_ 1785030842931740672
author Bailes, Anna H
Johnson, Marit E.
Redfern, Mark
Perera, Subashan
Greco, Carol
Sowa, Gwendolyn
Cham, Rakie
Bell, Kevin
author_facet Bailes, Anna H
Johnson, Marit E.
Redfern, Mark
Perera, Subashan
Greco, Carol
Sowa, Gwendolyn
Cham, Rakie
Bell, Kevin
author_sort Bailes, Anna H
collection PubMed
description OBJECTIVES/GOALS: Chronic low back pain (cLBP) is associated with gait impairments. Gait may serve as an important biomarker for improvement following therapy interventions; however, gait has not been sufficiently studied in relationship to pain and function in cLBP. METHODS/STUDY POPULATION: Adults with cLBP completed a two-minute-walk-test around a 37.5 m oval track while wearing an inertial measurement unit (IMU—Lifeware LLC, Pittsburgh, PA) over the L5 spinous process. Step time average, step time variability, step length, and symmetry (harmonic ratio) were calculated based on linear trunk accelerations, and gait speed was calculated based on distance walked. Participants completed the PEG tool (Pain, Enjoyment, General activity; scores closer to 10 indicate worse pain) to quantify pain intensity/interference and the PROMIS Physical Function SF-6b tool (mean t-scores=50 +/- 10; higher scores indicate better function) to quantify physical function. Pearson correlation coefficient (r) was used to determine strength of associations between gait and pain/physical function. RESULTS/ANTICIPATED RESULTS: Eleven adults (8 female, age 40 +/- 17, pain duration≥3 months) with cLPB participated in this study after completing an informed consent process approved by the University of Pittsburgh Institutional Review Board. Participants with a history of cancer, spinal cord compression, discitis, or activity restrictions prohibiting them from protocol completion were excluded. The mean PEG scores and PROMIS Physical Function t-scores were 2.8 +/- 1.8 and 47.8 +/- 8.2 respectively. There was a moderate-strong correlation between step time average and PEG (r=0.67, p=0.02), and a moderate-strong correlation between gait speed and PROMIS Physical Function (r=0.62, p=0.04). There were no other significant associations. DISCUSSION/SIGNIFICANCE: Gait speed and step time may be important movement biomarkers to consider when evaluating patients with cLBP. Generalizability of results are limited by the small study cohort and this cohort's relatively low pain burden and high level of physical function.
format Online
Article
Text
id pubmed-10129838
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-101298382023-04-26 283 Gait: a biomarker for pain and function in chronic low back pain Bailes, Anna H Johnson, Marit E. Redfern, Mark Perera, Subashan Greco, Carol Sowa, Gwendolyn Cham, Rakie Bell, Kevin J Clin Transl Sci Precision Medicine/Health OBJECTIVES/GOALS: Chronic low back pain (cLBP) is associated with gait impairments. Gait may serve as an important biomarker for improvement following therapy interventions; however, gait has not been sufficiently studied in relationship to pain and function in cLBP. METHODS/STUDY POPULATION: Adults with cLBP completed a two-minute-walk-test around a 37.5 m oval track while wearing an inertial measurement unit (IMU—Lifeware LLC, Pittsburgh, PA) over the L5 spinous process. Step time average, step time variability, step length, and symmetry (harmonic ratio) were calculated based on linear trunk accelerations, and gait speed was calculated based on distance walked. Participants completed the PEG tool (Pain, Enjoyment, General activity; scores closer to 10 indicate worse pain) to quantify pain intensity/interference and the PROMIS Physical Function SF-6b tool (mean t-scores=50 +/- 10; higher scores indicate better function) to quantify physical function. Pearson correlation coefficient (r) was used to determine strength of associations between gait and pain/physical function. RESULTS/ANTICIPATED RESULTS: Eleven adults (8 female, age 40 +/- 17, pain duration≥3 months) with cLPB participated in this study after completing an informed consent process approved by the University of Pittsburgh Institutional Review Board. Participants with a history of cancer, spinal cord compression, discitis, or activity restrictions prohibiting them from protocol completion were excluded. The mean PEG scores and PROMIS Physical Function t-scores were 2.8 +/- 1.8 and 47.8 +/- 8.2 respectively. There was a moderate-strong correlation between step time average and PEG (r=0.67, p=0.02), and a moderate-strong correlation between gait speed and PROMIS Physical Function (r=0.62, p=0.04). There were no other significant associations. DISCUSSION/SIGNIFICANCE: Gait speed and step time may be important movement biomarkers to consider when evaluating patients with cLBP. Generalizability of results are limited by the small study cohort and this cohort's relatively low pain burden and high level of physical function. Cambridge University Press 2023-04-24 /pmc/articles/PMC10129838/ http://dx.doi.org/10.1017/cts.2023.339 Text en © The Association for Clinical and Translational Science 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Precision Medicine/Health
Bailes, Anna H
Johnson, Marit E.
Redfern, Mark
Perera, Subashan
Greco, Carol
Sowa, Gwendolyn
Cham, Rakie
Bell, Kevin
283 Gait: a biomarker for pain and function in chronic low back pain
title 283 Gait: a biomarker for pain and function in chronic low back pain
title_full 283 Gait: a biomarker for pain and function in chronic low back pain
title_fullStr 283 Gait: a biomarker for pain and function in chronic low back pain
title_full_unstemmed 283 Gait: a biomarker for pain and function in chronic low back pain
title_short 283 Gait: a biomarker for pain and function in chronic low back pain
title_sort 283 gait: a biomarker for pain and function in chronic low back pain
topic Precision Medicine/Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129838/
http://dx.doi.org/10.1017/cts.2023.339
work_keys_str_mv AT bailesannah 283gaitabiomarkerforpainandfunctioninchroniclowbackpain
AT johnsonmarite 283gaitabiomarkerforpainandfunctioninchroniclowbackpain
AT redfernmark 283gaitabiomarkerforpainandfunctioninchroniclowbackpain
AT pererasubashan 283gaitabiomarkerforpainandfunctioninchroniclowbackpain
AT grecocarol 283gaitabiomarkerforpainandfunctioninchroniclowbackpain
AT sowagwendolyn 283gaitabiomarkerforpainandfunctioninchroniclowbackpain
AT chamrakie 283gaitabiomarkerforpainandfunctioninchroniclowbackpain
AT bellkevin 283gaitabiomarkerforpainandfunctioninchroniclowbackpain